Pharmacokinetics and pharmacodynamics of the oral direct thrombin inhibitor ximelagatran co-administered with different classes of antibiotics in healthy volunteers

被引：0
|
作者：
Hassan Dorani
Kajs-Marie Schützer
Troy C. Sarich
Ulrika Wall
Ulrika Logren
Lis Ohlsson
Ulf G. Eriksson
机构：
[1] AstraZeneca Research and Development,Experimental Medicine
[2] AstraZeneca LP,undefined
[3] Johnson and Johnson Pharmaceutical Research and Development,undefined
来源：
European Journal of Clinical Pharmacology | 2007年 / 63卷
关键词：
Ximelagatran; Melagatran; Antibiotic interactions; Oral direct thrombin inhibitors; P-glycoprotein pump (p-GP);
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：571 / 581
页数：10
相关论文
共 50 条
  • [1] Pharmacokinetics and pharmacodynamics of the oral direct thrombin inhibitor ximelagatran co-administered with different classes of antibiotics in healthy volunteers
    Dorani, Hassan
    Schutzer, Kajs-Marie
    Sarich, Troy C.
    Wall, Ulrika
    Logren, Ulrika
    Ohlsson, Lis
    Eriksson, Ulf G.
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2007, 63 (06) : 571 - 581
  • [2] The pharmacokinetics and pharmacodynamics of the oral direct thrombin inhibitor ximelagatran when administered with verapamil
    Eriksson, UG
    Dorani, H
    Panfilov, S
    Wall, U
    Ohlsson, L
    Sarich, TC
    JOURNAL OF CLINICAL PHARMACOLOGY, 2005, 45 (09): : 1077 - 1077
  • [3] The pharmacokinetics and pharmacodynamics of the oral direct thrombin inhibitor ximelagatran when administered with azithromycin and cefuroxime
    Dorani, H
    Schützer, K
    Sarich, T
    Wall, U
    Ohlsson, L
    Eriksson, U
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2005, 77 (02) : P83 - P83
  • [4] Pharmacokinetics and Pharmacodynamics of the Oral Direct Thrombin Inhibitor Ximelagatran in Young Healthy Japanese Men
    Linda C. Wernevik
    Per Nyström
    Gillis Johnsson
    Takashi Nakanishi
    Ulf G. Eriksson
    Clinical Pharmacokinetics, 2006, 45 : 77 - 84
  • [5] Pharmacokinetics and pharmacodynamics of the oral direct thrombin inhibitor ximelagatran in young healthy Japanese men
    Wernevik, LC
    Nyström, P
    Johnsson, G
    Nakanishi, T
    Eriksson, UG
    CLINICAL PHARMACOKINETICS, 2006, 45 (01) : 77 - 84
  • [6] Influence of Age on the Pharmacokinetics and Pharmacodynamics of Ximelagatran, an Oral Direct Thrombin Inhibitor
    Linda C. Johansson
    Lars Frison
    Ulrika Logren
    Gunnar Fager
    David Gustafsson
    Ulf G. Eriksson
    Clinical Pharmacokinetics, 2003, 42 : 381 - 392
  • [7] Pharmacokinetics and pharmacodynamics of ximelagatran, a novel oral direct thrombin inhibitor, in young healthy male subjects
    Ulf G. Eriksson
    Ulf Bredberg
    Kristina Gislén
    Linda C. Johansson
    Lars Frison
    Martin Ahnoff
    David Gustafsson
    European Journal of Clinical Pharmacology, 2003, 59 : 35 - 43
  • [8] Influence of age on the pharmacokinetics and pharmacodynamics of ximelagatran, an oral direct thrombin inhibitor
    Johansson, LC
    Frison, L
    Logren, U
    Fager, G
    Gustafsson, D
    Eriksson, UG
    CLINICAL PHARMACOKINETICS, 2003, 42 (04) : 381 - 392
  • [9] Pharmacokinetics and pharmacodynamics of ximelagatran, a novel oral direct thrombin inhibitor, in young healthy male subjects
    Eriksson, UG
    Bredberg, U
    Gislén, K
    Johansson, LC
    Frison, L
    Ahnoff, M
    Gustafsson, D
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2003, 59 (01) : 35 - 43
  • [10] Evaluation of the pharmacokinetics and pharmacodynamics of ticagrelor co-administered with aspirin in healthy volunteers
    Teng, Renli
    Maya, Juan
    Butler, Kathleen
    PLATELETS, 2013, 24 (08) : 615 - 624
12345